Issue Date: February 26, 2007
Germany's Merck Shifts Head Again
Merck KGaA has named Karl-Ludwig Kley as chairman, effective April 27. Kley replaces Michael Roemer, a longtime company executive who took the position in November 2005 following the abrupt departure of Bernhard Scheuble. Kley, who has been vice chairman of Merck's executive board since last September, is credited as an architect of the company's new pharmaceutical division, Merck Serono.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society